AFAngus Forbes

Angus Forbes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Angus Forbes has a total of 410 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association between depression and the development of end‐stage kidney disease in people with diabetes: A population‐based cohort study

    by Hellena Hailu Habte‐Asres, Sarah Afuwape, Adrian Heald, David C. Wheeler, Angus Forbes

    Introduction: Diabetes is the leading cause of end‐stage kidney disease (ESKD; CKD stage 5). Depression is common among people with diabetes and CKD and is associated with poorer outcomes. However, its relationship with progression to ESKD remains unclear, particularly given the competing risk of death. We examined the association between depression and progression to ESKD in people with diabetes and CKD. Methods: We conducted a retrospective population‐based cohort study using UK primary care data from the Clinical Practice Research Datalink. Adults aged ≥ 18 years with diabetes and CKD stages 1–4 were included. Depression was defined by the presence of a depression Read code together with ≥ 12 months of continuous antidepressant prescribing during the baseline period. The primary outcome was progression to ESKD. We compared the risk of progression to ESKD between people with and without depression, accounting for differences in demographic, socioeconomic and clinical characteristics, as well as the competing risk of death. Results: Among 58,769 individuals (mean age 76.8 ± 10.2 years; 45.5% male), 14.3% had depression. Over a mean follow‐up of 5.6 ± 3.4 years, 1720 progressed to ESKD and 25,127 died before ESKD. Depression was associated with a lower sub‐distribution hazard of ESKD in crude (SHR 0.67; 95% CI 0.57–0.78) and adjusted analyses (SHR 0.82; 95% CI 0.68–0.99). Older age was associated with a lower cumulative incidence of ESKD. Conclusions: After accounting for the competing risk of death, depression was associated with a lower observed cumulative incidence of ESKD. This paradoxical finding may reflect competing mortality or residual confounding.

  • Open Access

    Women living with diabetes: Overlooked and under‐recognised, the psychosocial impact

    by Rita Forde, Angus Forbes, Dawn Adams, Aycan Celik Esmer, Emma Davidsen, Maartje de Wit, Michelle Hadjiconstantinou, Rahab Hashim, Ana Munda, Giesje Nefs, et al.

    Aim: Diabetes intersects with women's reproductive and sexual health across the life course; however, the psychosocial implications of key reproductive transitions remain under‐recognised in research and clinical practice. This review synthesised evidence on the psychosocial impacts of diabetes during menstruation, pregnancy, the menopausal transition and sexual functioning, with the aim of identifying critical gaps in research and care. Methods: A narrative review was conducted, informed by a semi‐structured literature search. Findings: Women living with diabetes experience substantial psychosocial burdens that extend beyond glycaemic management across all reproductive stages. During menstruation, hormonal fluctuations contribute to glycaemic variability, increased self‐management demands and emotional distress, often without adequate clinical guidance. Pregnancy in women with type 1, type 2, and gestational diabetes is associated with heightened anxiety, diabetes distress, stigma and guilt, yet psychosocial needs remain largely unaddressed in routine care. The menopausal transition represents a further period of vulnerability, characterised by worsening glycaemic variability, increased psychological morbidity and elevated cardiovascular risk. Sexual dysfunction is highly prevalent across the lifespan in women with diabetes and is strongly associated with depression, anxiety and body image concerns. Conclusion: Overall, the evidence highlights a persistent disconnect between the psychosocial needs of women and the predominantly biomedical focus of current diabetes care models. Addressing this gap requires a person‐centred approach that integrates psychosocial and women‐specific health considerations into diabetes research, education and clinical practice. Strengthening this evidence base is essential to improving long‐term health outcomes for women living with diabetes.


  • Open Access

    Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review

    by Molly Caba, Márcia Carvalho, Angus Forbes, Rita Forde, Kirandip Gill, Mohsin Khalifa, Judith Parsons, Jane Speight, Paula M. Trief, Michelle Hadjiconstantinou

    Aims: To review the literature on psychosocial care and experiences of young adults with early‐onset type 2 diabetes (EOT2D), to identify what is known, current gaps and to develop recommendations to help advance psychosocial care and support for the population. Methods: We searched Medline (Ovid), Google Scholar and diabetes‐specific journals for English‐language articles focused on psychosocial aspects in young adults (aged 18–45 years) with EOT2D. Two people with lived experience reviewed and commented on the review findings. Results: Growing evidence indicates that a diagnosis of EOT2D is associated with an increased risk of developing diabetes‐related psychological comorbidities. Experiences of diabetes‐related stigma, compounded by age‐related negative preconceptions, contribute to heightening the psychosocial impact of EOT2D. Some population sub‐groups appear to be more likely to experience adverse psychological effects. However, the evidence base is limited by a dearth of diverse research specifically focused on the psychosocial experiences and needs of this population (e.g., longitudinal and qualitative studies). Adults with EOT2D also experience unmet education, care and support needs relevant to optimising their psychosocial well‐being and diabetes management. Overall, they require enhanced, tailored care and support that is age‐appropriate, person‐centred and responsive to their psychosocial needs. Digital technology and support‐based strategies may help to address current gaps and improve the psychological well‐being of this group, but these require further exploration. Conclusions: Despite the importance of psychosocial factors in young adults' diabetes management and outcomes, there remain gaps in research and practice and the need for further research, alongside changes in practice.


  • Open Access

    A mobile phone application for the prevention of type 2 diabetes in Malaysian women with gestational diabetes mellitus ( MYGODDESS ): A feasibility randomised controlled trial

    by Madeleine Benton, Kimberley Goldsmith, Siew Mooi Ching, Angus Forbes, Iliatha Papachristou Nadal, Helen R. Murphy, Nur Hafizah Mahamad Sobri, Barakatun‐Nisak Mohd Yusof, Nurul Iftida Basri, Irmi Zarina Ismail, et al.

    Aims: The prevalence of gestational diabetes mellitus (GDM) in Malaysia is estimated at 9–18%. Although GDM is associated with increased and potentially modifiable risk of developing type 2 diabetes, the effectiveness of diabetes prevention interventions (DPI) post‐GDM in this setting is unclear. To evaluate the feasibility of conducting a future full‐scale, two‐arm, parallel, randomised controlled trial (RCT) of a DPI in women with GDM set in Malaysia. Methods: Women in both arms received usual GDM care. Women in the intervention arm also received modules on diet, physical activity, and mental health via a mobile application, over six months post‐partum, plus dietitian‐led group sessions and motivational text messages. The primary feasibility outcomes included the proportion of women who consented, were eligible and randomised and provided outcome data. We measured biomedical and mental health outcomes for a full‐scale RCT at four time points: baseline before randomisation (approximately 30 weeks' gestation), 36 weeks' gestation and 3‐ and 6‐months postpartum. Results: We screened 660 women with GDM, 294 (45%) consented for eligibility screening, of whom 164 (24.9%) were eligible and 60 (9%) consented and were randomised. The proportion who completed biomedical outcomes was 85% at each follow‐up. There was no treatment effect on any other biomedical outcomes or secondary outcomes. Conclusions: The participation rate was in keeping with previous DPI trials and the attrition rate was low, suggesting it is feasible to conduct a full‐scale RCT.


  • Open Access

    ‘Why, Can I Not Have Control of My Own Insulin?’: Qualitative Exploration Amongst Older Adults With Diabetes With Lived Experience of Surgical Hospital Admission

    by Christina Lange Ferreira, Hellena Habte‐Asres, Angus Forbes, Kirsty Winkley

    Aim: To explore the experiences and perspectives of older adults living with diabetes, in relation to insulin management during a surgical hospital admission and identify factors that appear to be associated with insulin safety in these older people. To identify key messages that address people with diabetes priorities, to be used in staff education. Methods: Qualitative study, conducted in a single, rural NHS hospital. Ten semi‐structured phone interviews were held with older adults with diabetes, with or without frailty, treated with insulin while undergoing surgical hospital admission. Framework analysis was employed in data analysis. Results: Six people with type 2 diabetes and four people with type 1 diabetes, aged 68 to 91 years old (mean age 77.2 years [SD = 6.2]) participated in the study. Four themes identified specific to hospital insulin management and safety: (1) preparedness for hospital admission; (2) feeling disempowered in hospital; (3) staff knowledge, confidence, attitudes and behaviours; (4) diabetes and insulin management as a balancing act. In addition, participants co‐designed an infographic to help hospital staff understand what matters most to older adults in terms of managing their insulin safely in the hospital. Conclusion: Lack of joined‐up care, staff knowledge gaps and lack of empowerment ethos hinder hospital insulin safety. This study identified that having a self‐management policy in a hospital does not necessarily mean it is implemented for older adults with diabetes. Using a co‐design approach to engage with older adults helped to identify components critical to hospital insulin safety interventions. Patient or Public Contribution: Patients and members of the public are involved in study design and interpretation of findings. Before the study, a diabetes peer‐support group reviewed and contributed to the interview topic guide and study recruitment documentation. Study participants co‐designed the infographic developed.


  • Open Access

    Barriers and facilitators to oral healthcare support in gestational diabetes mellitus: An interview study with healthcare professionals

    by Camilla Böhme Kristensen, Koula Asimakopoulou, Mark Ide, Angus Forbes

    Aim: Periodontitis is a chronic inflammatory oral disease characterised by the persistent activation of immune cells, which contributes to insulin resistance and, consequently, an increased risk of systemic diseases, including gestational diabetes mellitus (GDM). At the same time, the risk of periodontitis is higher in individuals with diabetes, with higher glycaemic levels being the primary contributing factor. Oral health review is also advised in diabetes care by the NICE guidelines, because of its impact on blood glucose management. However, oral health may be overlooked in GDM due to the volume of other interventions required. Furthermore, little is known about the barriers and facilitators to oral healthcare support among healthcare professionals (HCPs) working in GDM care. To examine the barriers and facilitators to oral healthcare support among HCPs in GDM care. Methods: The interview guide was based on the Theoretical Domains Framework (TDF), and semi‐structured interviews were used for data collection. The sample consisted of UK‐based HCPs with different professional backgrounds. Results: Four barriers and three facilitators were identified. These are related to the following TDF domains: professional role and identity; beliefs about consequences; knowledge; skills; memory, attention, and decision processes; and environmental context and resources. Conclusions: Oral health was not prioritised in GDM care. Furthermore, limited knowledge, increasing demands and time constraints, and fear of health‐related information overload were barriers to oral healthcare support. Training and education to increase knowledge, perceived importance of oral health and the HCPs' role and responsibilities facilitated oral healthcare support.

  • Open Access

    Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population‐based study in Salford, Manchester

    by Hellena Hailu Habte‐Asres, Mike Stedman, Angus Forbes, Janaka Karalliedde, David C. Wheeler, Adrian H. Heald

    Aims: Chronic kidney disease (CKD) is a serious and common complication of type 1 diabetes (T1D). Despite improvements in diabetes management, the prevalence of CKD in people with T1D remains high. However, large‐scale, real‐world data from the UK are limited. This study aimed to provide contemporary estimates of CKD incidence and its associated risk factors in a population with T1D in Salford, Greater Manchester. Methods: We conducted a retrospective cohort study using anonymised electronic health records from the Salford Integrated Record Research Database between 2010 and 2023. Adults with T1D were assessed for CKD, defined as an estimated glomerular filtration rate (eGFR) 2 and/or albuminuria (urine albumin‐to‐creatinine ratio ≥3 mg/mmol), confirmed by two readings at least 90 days apart. Competing risk regression models (accounting for death as a competing event) were used to identify associations with demographic and clinical risk factors, including age, sex, ethnicity, deprivation, smoking, body mass index (BMI), HbA1c and use of ACE inhibitors or ARBs. Results: Among 1106 adults with T1D, 38.5% developed reduced eGFR, 47.2% had albuminuria, and 23.8% met both criteria for CKD. Older age was strongly associated with reduced eGFR: compared to those aged 18–28 years, the sub‐distribution hazard ratio (sHR) was 3.1 (95% CI: 2.0–5.0) for ages 42–54 and 8.6 (95% CI: 5.4–13.9) for ≥55 years. Other significant predictors included missing ethnicity data (sHR 1.5), higher BMI (sHR 1.1 per kg/m 2 ), higher HbA1c (sHR 1.1 per mmol/mol) and not being prescribed an ACE inhibitor or ARB (sHR 1.4). For albuminuria, increased risk was associated with female sex (sHR 1.3), missing ethnicity (sHR 1.4), higher HbA1c (sHR 1.1), current smoking (sHR 1.5), living in the second most deprived quintile (sHR 1.9) and being prescribed ACE inhibitors or ARBs (sHR 2.1). Conclusion: This large UK cohort study highlights a high burden of CKD among adults with T1D. Key risk factors included older age, higher BMI, poor glycaemic control, smoking and deprivation. Although ACE inhibitors and ARBs were commonly prescribed, the uptake of newer reno‐protective treatments was low. These findings point to a need for earlier detection, targeted interventions and broader implementation of effective therapies to reduce kidney disease burden in this population.


  • Top Cited Papers
    Open Access

    Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap

    by Mia Bajramagic, Tadej Battelino, Xavier Cos, Mark Cote, Nancy Cui, Angus Forbes, Alfonso Galderisi, Lutz Heinemann, Sufyan Hussain, Jessica Imbert, et al.

    The use of artificial intelligence (AI) to improve the diagnosis, assessment and treatment of people with diabetes has the potential to drive a paradigm shift in diabetes care, both minimising treatment inertia and optimising clinical outcomes. This is a significant opportunity, given the predicted increase in the burden of diabetes over the next 20 years. However, there are concerns that regulatory processes for development and implementation of AI-driven technologies are not adequate for systems that may adapt to new data and change from their original performance characteristics as evaluated. The European Diabetes Forum (EUDF) convened a working group to review and investigate the unmet needs around implementation of AI technology in diabetes care. The working group developed the framework and focus of the accompanying analysis through a series of virtual and face-to-face meetings, including email conversations. The working group examined the key objectives for good diabetes care in the context of current and predicted AI-driven clinical decision support systems (AI-CDSS), including the outcomes for people with diabetes, the goals for personalised medicine and the implications for guideline-driven diabetes services and healthcare professionals. The process covered the needs of primary care healthcare professionals, who will shoulder the majority of diabetes care. The challenge of developing regulatory concepts and processes that are sufficiently robust to be AI inclusive was considered as central to the outcomes. Based on the available evidence, the EUDF working group believes that AI-CDSS will deliver benefits for people with diabetes, although there are clear challenges to moving AI-CDSS into the practical clinical space. To encourage debate on how this can be achieved safely and effectively, at the conclusion of the process a series of 14 recommendations was agreed using a nominal group technique and Delphi methodology, which are discussed in context in this article. Graphical Abstract


  • Open Access

    ‘You decided I am old enough for the transition, but not old enough to have a say?’: Exploring young people’s, parents’, and healthcare providers’ views and experiences of Type 1 Diabetes paediatric to adult healthcare transition in Saudi Arabia

    by Nada Aljohani, Angus Forbes, Ghufran Daqrashawi, Mette Due-Christensen, Sara Donetto, Mariam Asaad, Vicki Tsianakas

    Background: Young people with Type 1 diabetes in Saudi Arabia transition from paediatric to adult care at a culturally defined age of 14, which is younger than the average transition age in Western societies. The aim of this study was to elicit the experiences of young people with Type 1 diabetes, their parents, and healthcare providers in Saudi Arabia as they transitioned from paediatric to adult care. Methods: In healthcare, Design Thinking is a human-centred approach that draws on participants’ experiences and perspectives to design and develop interventions, models, or services that meet the needs of stakeholders. This study reports the first inspiration phase of the Design Thinking process. Four parallel exploration workshops were held with pre- and post-transition young people with Type 1 diabetes (n = 12), their parents (n = 8), and healthcare providers (n = 7). Findings: Six key themes were identified from the workshops’ data analysis. For young people, the key themes were facing the unknown and preparedness; developing autonomy and recognition as an independent person; and interacting with the adult healthcare team. For parents, the themes were navigating the shift in parental role and involvement in care, interacting with healthcare professionals, and changing support needs. For healthcare providers, the key theme was balancing independence and care approaches. Conclusion: The Inspiration phase of the Design Thinking approach provided valuable insights from the healthcare transition experiences of young people with Type 1 diabetes, their parents, and healthcare providers in Saudi Arabia. The generated insights facilitated the identification of areas for interventions in the process’s following phases.


  • Open Access

    Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta‐analysis

    by Hellena Hailu Habte‐Asres, Frehiwot Hailu, Angus Forbes, David C. Wheeler, Tunde Peto

    Aim: People with diabetes receiving haemodialysis are at increased risk of diabetic retinopathy (DR) and other ocular complications. Despite this heightened vulnerability, evidence on the prevalence of such conditions in this population is limited. This review aimed to synthesise the existing literature on the prevalence of DR and other ocular conditions, and to evaluate screening rates in people with diabetes undergoing haemodialysis. Methods: A systematic search of MEDLINE, EMBASE and CINAHL databases was conducted to identify studies reporting on the prevalence of DR, diabetic maculopathy and other ocular conditions in people with diabetes on haemodialysis. Eight articles meeting inclusion criteria were included. Pooled prevalence estimates and 95% confidence intervals (CIs) were calculated using random‐effects models. Results: The pooled prevalence of DR was 49.1% (95% CI: 23.1–75.4), while diabetic maculopathy prevalence was 32.5% (95% CI: 10.9–59.1). Other ocular complications reported included cataracts (53.4%), conjunctival calcification (63%) and corneal calcification (45.3%). Notably, 54.3% (95% CI: 35.4–72.6) of individuals on haemodialysis had not undergone eye screening in over two years. Conclusion: This review reveals a high prevalence of DR and other ocular complications in people with diabetes undergoing haemodialysis, alongside significant under‐screening. Future research should focus on developing and accessing targeted interventions to improve screening uptake in this vulnerable population.